The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, Ad26.COV2.S, developed by Johnson & Johnson’s subsidiary, Janssen Biotech. This marks the third vaccine authorized by the FDA to combat COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Details of the Authorization: The […]
Micro Labs and Mylan Pharmaceuticals have secured approval from the US Food and Drug Administration (FDA) for two applications for the first generics of Eliquis (apixaban) tablets to cut down the risk of stroke and systemic embolism in patients having nonvalvular atrial fibrillation. Apixaban is also indicated for the preventive treatment of deep vein thrombosis […]
